We obtained complementary DNA (cDNA) from the leukemia-derived cells and the healthy PBMCs, and determined expression of WNT4 by quantitative Reverse transcriptase-Polymerase chain reaction (qRT-PCR) in all samples. The gene discussed is WNT4; the disease is leukemia.